Active substanceFusidic acidFusidic acid
Dosage form: & nbspcream for external use
Composition:
Active substance:
Fusidic acid (Fusidic acid) -2.0 g
Excipients:
emulsifier №1 . - 7.0 g
glycerol (glycerin distilled) -12.0 g
paraffin liquid (oil vaseline) - . -3.0 g
potassium sorbate (E 202) -0.15 g
butyl hydroxy anisole (E 320) -0.001 g
polysorbate-80 (tween-80) -0.7 g. ,
Vaseline medical white: -'11.0 g
purified water to 100 g
Description:cream white or white with a yellowish hue.
Pharmacotherapeutic group:antibiotic of polycyclic structure
ATX: & nbsp

D.09.A.A.02   Fusidic acid

Pharmacodynamics:
Fusidic acid refers to the group of fusidins, antimicrobial compounds whose mechanism of action is associated with a violation of protein synthesis in a bacterial cell. By blocking the elongation of factor G, they prevent its binding to ribosomes and GTP (guanosine triphosphate), which interrupts the release of energy required for synthesis.
Fusidic acid is sensitive to gram-positive bacteria and Gram-negative cocci, for example, Staphylococcus aureus, Coryriebacterium minutissimum, Streptococcus pyogenes, Pseudomonas spp., Clostridium spp
'Inactive with Escherichia coli, Salmonella spp.', Proteus spp. th other gram-negative bacteria, as well as protozoa and fungi.

Pharmacokinetics:
The permeability of fusidic acid through intact skin is 0.54% of the applied amount of the drug

Indications:
Bacterial skin infections in adults; adolescents, children, impetigo, furunculosis, pyoderma, hydradenitis, burns, abrasions, sycosis, infected wounds and ulcerous surfaces.

Contraindications:
Hypersensitivity to any component of the drug. ... \

Pregnancy and lactation:Experimental data do not confirm embryotoxic or teratogenic effects of the drug. Use with caution during pregnancy and lactation, apply only if the intended benefit to the mother exceeds the risk to the fetus and the baby. '
Dosing and Administration:
Outer, after removal of pus and necrotic masses are applied to the affected surface, the skin with a thin layer 1-2 times a day. The course of treatment is 10 days .;

Side effects:. When applying the drug, the following side effects are possible: rash (erythematous, maculopapular, pustular), dry skin, irritation at the site of application (including pain, burning sensation and pricking), itching, contact dermatitis, urticaria, angioedema, eczema; periorbital edema, erythema; allergic reactions.
Overdose:no data
Interaction:There is no data on the interaction with external use of fusidic acid. '
Special instructions:
Do not apply in the eye area, as this can cause irritation of the conjunctiva.
When using fusidic acid, bacterial resistance may develop. As with other antibiotics, prolonged or recurring use may increase the risk of developing resistance to the drug.

Effect on the ability to drive transp. cf. and fur:
Influence on driving and complex mechanisms is not revealed.

Form release / dosage:
Cream for external use 2% '.
Packaging:
For 15 g in tubes of aluminum.
One tube with the instruction for use is placed in a cardboard box.
Storage conditions:In a dry, protected from light place, at a temperature not higher than 15 С. Keep out of the reach of children
Shelf life:
2 years. Do not use after the expiry date printed on the package. '

Terms of leave from pharmacies:On prescription
Registration number:LP-000648
Date of registration:28.09.2011
The owner of the registration certificate:BIOSINTEZ, PAO BIOSINTEZ, PAO Russia
Manufacturer: & nbsp
Representation: & nbspBIOSINTEZ JSC BIOSINTEZ JSC Russia
Information update date: & nbsp27.09.2015
Illustrated instructions
    Instructions
    Up